Premier Laser Systems' Centauri granted investigational new device exemption (IDE):
This article was originally published in Clinica
Premier Laser Systems has been granted an IDE by the US FDA to carry out final clinical testing of its Centauri laser system. The portable, solid-state pulsed Erbium:YAG laser is for cavity preparation, decay removal and other hard tissue dental procedures. The company will complete a 120-patient study and then conduct a 90-day follow-up to determine the efficacy of the laser including its new reusable delivery fibres.
You may also be interested in...
The Pink Sheet explains the procedures underpinning the UK’s emergency use authorization of the Pfizer/BioNTech COVID-19 vaccine.
The US Food and Drug Administration posted two device-related closeout letters in November.
Jazz and PharmaMar need to see what further data will be needed to convert their FDA authorization into a full approval following disappointing results in the ATLANTIS Phase III trial.